日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world data and clinical experience from over 100,000 multi-cancer early detection tests

来自超过 10 万例多癌种早期检测的真实世界数据和临床经验

Matrana, Marc; Shukla, Vershalee; Kingsbury, Dallas; Poliak, Martin; Lipton, Jordan; McMillin, Matthew; Malinow, Louis B; Venn, Oliver; Beausang, John F; Stanley, Geoff; Hubbell, Earl; Kurtzman, Kathryn N; Venstrom, Jeffrey M; Shaknovich, Rita; Westgate, Candace

A Targeted Methylation-Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease

一种基于靶向甲基化的多癌种早期检测血液检测方法,可优先检测高级别前列腺癌,同时最大限度地减少对惰性疾病的过度诊断。

Mahal, Brandon A; Margolis, Matthew; Hubbell, Earl; Chen, Cheng; Venstrom, Jeffrey M; Abran, John; Kartlitz, Jordan J; Wyatt, Alexander W; Klein, Eric A

Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen

长期随访证实,在接受利妥昔单抗维持治疗的滤泡性淋巴瘤患者中,肿瘤浸润性 CD3 T 细胞数量高具有良好的预后意义。

Laurent, Camille; Flores, Maria; Chartier, Loïc; Huet, Sarah; Bolen, Christopher R; Venstrom, Jeffrey M; Chassagne-Clément, Catherine; Dartigues-Cuilléres, Peggy; Charlotte, Fréderic; Tesson, Bruno; Salles, Gilles; Morschhauser, Franck; Xerri, Luc

Chromosome 8q arm overexpression is associated with worse prostate cancer prognosis

8q染色体臂过度表达与前列腺癌预后不良相关

Alshalalfa, Mohammed; Nguyen, Tiffany T; Stopsack, Konrad H; Khan, Anwar; Franco, Idalid; Seldon, Crystal; Swami, Nishwant; Jin, William; Meiyappan, Karthik; Ton, Minh; Venstrom, Jeffrey M; Dee, Edward Christopher; Mahal, Brandon A

The Genomics of Colorectal Cancer in Populations with African and European Ancestry

非洲裔和欧洲裔人群结直肠癌的基因组学研究

Myer, Parvathi A; Lee, Jessica K; Madison, Russell W; Pradhan, Kith; Newberg, Justin Y; Isasi, Carmen R; Klempner, Samuel J; Frampton, Garrett M; Ross, Jeffery S; Venstrom, Jeffrey M; Schrock, Alexa B; Das, Sudipto; Augenlicht, Leonard; Verma, Amit; Greally, John M; Raj, Srilakshmi M; Goel, Sanjay; Ali, Siraj M

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma

临床基因组分析在软组织和骨肉瘤患者管理中的应用

Gounder, Mrinal M; Agaram, Narasimhan P; Trabucco, Sally E; Robinson, Victoria; Ferraro, Richard A; Millis, Sherri Z; Krishnan, Anita; Lee, Jessica; Attia, Steven; Abida, Wassim; Drilon, Alexander; Chi, Ping; Angelo, Sandra P D'; Dickson, Mark A; Keohan, Mary Lou; Kelly, Ciara M; Agulnik, Mark; Chawla, Sant P; Choy, Edwin; Chugh, Rashmi; Meyer, Christian F; Myer, Parvathi A; Moore, Jessica L; Okimoto, Ross A; Pollock, Raphael E; Ravi, Vinod; Singh, Arun S; Somaiah, Neeta; Wagner, Andrew J; Healey, John H; Frampton, Garrett M; Venstrom, Jeffrey M; Ross, Jeffrey S; Ladanyi, Marc; Singer, Samuel; Brennan, Murray F; Schwartz, Gary K; Lazar, Alexander J; Thomas, David M; Maki, Robert G; Tap, William D; Ali, Siraj M; Jin, Dexter X

The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA

循环肿瘤DNA中可靶向激酶融合的泛肿瘤图谱

Lee, Jessica K; Hazar-Rethinam, Mehlika; Decker, Brennan; Gjoerup, Ole; Madison, Russell W; Lieber, Daniel S; Chung, Jon H; Schrock, Alexa B; Creeden, James; Venstrom, Jeffrey; Alexander, Brian; Oxnard, Geoffrey R

Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)

癌症体细胞变异致病性(致癌性)分类标准:临床基因组资源(ClinGen)、癌症基因组学联盟(CGC)和癌症变异解读联盟(VICC)的联合建议

Horak, Peter; Griffith, Malachi; Danos, Arpad M; Pitel, Beth A; Madhavan, Subha; Liu, Xuelu; Chow, Cynthia; Williams, Heather; Carmody, Leigh; Barrow-Laing, Lisa; Rieke, Damian; Kreutzfeldt, Simon; Stenzinger, Albrecht; Tamborero, David; Benary, Manuela; Rajagopal, Padma Sheila; Ida, Cristiane M; Lesmana, Harry; Satgunaseelan, Laveniya; Merker, Jason D; Tolstorukov, Michael Y; Campregher, Paulo Vidal; Warner, Jeremy L; Rao, Shruti; Natesan, Maya; Shen, Haolin; Venstrom, Jeffrey; Roy, Somak; Tao, Kayoko; Kanagal-Shamanna, Rashmi; Xu, Xinjie; Ritter, Deborah I; Pagel, Kym; Krysiak, Kilannin; Dubuc, Adrian; Akkari, Yassmine M; Li, Xuan Shirley; Lee, Jennifer; King, Ian; Raca, Gordana; Wagner, Alex H; Li, Marylin M; Plon, Sharon E; Kulkarni, Shashikant; Griffith, Obi L; Chakravarty, Debyani; Sonkin, Dmitriy

ERBB2 Copy Number as a Quantitative Biomarker for Real-World Outcomes to Anti-Human Epidermal Growth Factor Receptor 2 Therapy in Advanced Gastroesophageal Adenocarcinoma

ERBB2拷贝数作为晚期胃食管腺癌抗人表皮生长因子受体2疗法真实世界疗效的定量生物标志物

Zhang, Liangliang; Hamdani, Omar; Gjoerup, Ole; Cho-Phan, Cheryl; Snider, Jeremy; Castellanos, Emily; Nimeiri, Halla; Frampton, Garrett; Venstrom, Jeffrey M; Oxnard, Geoffrey; Klempner, Samuel J; Schrock, Alexa B

APOBEC Mutational Signatures in Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers Are Associated With Poor Outcomes on CDK4/6 Inhibitors and Endocrine Therapy

在激素受体阳性、人表皮生长因子受体2阴性的乳腺癌中,APOBEC突变特征与CDK4/6抑制剂和内分泌治疗的不良预后相关。

Sammons, Sarah; Raskina, Kira; Danziger, Natalie; Alder, Laura; Schrock, Alexa B; Venstrom, Jeffrey M; Knutson, Keith L; Thompson, E Aubrey; McGregor, Kim; Sokol, Ethan; Chumsri, Saranya